Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Immunosuppressive Drugs Companies

Immunosuppressive drugs are medications that suppress the activity of the immune system. These drugs are commonly used in organ transplantation to prevent the body from rejecting a transplanted organ. They are also prescribed for certain autoimmune disorders where the immune system mistakenly attacks the body's own tissues.

Top Industry Leaders in the Immunosuppressive Drugs Market

Immunosuppressive Drugs Key Companies

Latest Immunosuppressive Drugs Companies Update:

Pfizer (US) announces positive phase 3 trial results for its investigational IL-23 inhibitor etrasimod for the treatment of moderate-to-severe ulcerative colitis.

Roche (Switzerland) receives FDA approval for Actemra (tocilizumab) for the treatment of macrophage activation syndrome (MAS) in children and adults.

Bristol Myers Squibb (US) and Takeda Pharmaceutical Company Limited (Japan) collaborate to develop and commercialize a novel anti-CD40 monoclonal antibody for the treatment of autoimmune diseases.

Novartis (Switzerland) acquires Gyroscope Therapeutics Inc. (US) for USD 800 million, gaining access to GT004, a potential best-in-class IL-17A inhibitor for various autoimmune diseases.

Sanofi (France) expands its portfolio of immunosuppressive drugs with the acquisition of Amun Therapeutics Inc. (US), gaining access to a pipeline of novel immune-tolerizing therapies.

List of Immunosuppressive Drugs Key companies in the market

Accord Healthcare (UK)

Astella Pharma (Japan)

Bristol-Myers Squibb Company (US)

Genzyme Co. (Switzerland)

Hoffmann-La Roche AG (US

GlaxoSmithKline PLC (UK)

Glenmark Pharmaceuticals, Inc. (India)

Mylan Laboratories Inc. (US)

Pfizer Inc. (US)

Novartis AG (Switzerland)

Actavis, Inc.

Immunosuppressive Drugs Market Highlights:

Immunosuppressive Drugs Market Size

Immunosuppressive Drugs Market Trends

Immunosuppressive Drugs Market Analysis

Immunosuppressive Drugs Market Share

Immunosuppressive Drugs Market Highlights:

Immunosuppressive Drugs Market Trends

Immunosuppressive Drugs Market Analysis

Immunosuppressive Drugs Market Share

Immunosuppressive Drugs Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.